Skip to content
Search AI Powered

Latest Stories

PSNC publishes guidance for pharmacies ahead of HRT PPC rollout

The Pharmaceutical Services Negotiating Committee (PSNC) has published a guidance for community pharmacies to help them in the implementation of the new Prescription Prepayment Certificate (PPC) for hormone replacement therapy (HRT).

The new policy will rollout from 1 April 2023, patients who are not already exempt from NHS prescription charges will be able to purchase an annual HRT PPC for the cost of two single prescription charges


Major concern raised by PSNC is that the NHS systems have not kept pace with policy, as the certificate is launching without the IT in place to support it.

PSNC has been clear that this is totally unacceptable, including raising this with Ministers directly and warning them that introducing the PPC without this infrastructure risks causing confusion for some patients and adding to the burden for pharmacy teams.

“Government recognises the challenges but is determined to move forwards with the policy, said the committee. “DHSC has recognised the impact this will have on pharmacies and we are still pressing for appropriate financial compensation. We have also sought guidance for GPs, and now published our own guidance to try to make the launch go as smoothly as it can for pharmacy teams.”

Ahead of the launch of the HRT PPC, PSNC Chief Executive Janet Morrison said: “The HRT PPC being introduced by Government next month is a positive development for patients – indeed, we argued that these medicines should have been made available for free – but NHS systems have not kept pace with policy, meaning the certificate is launching without the IT in place to support it.

“This is totally unacceptable: community pharmacies cannot on the one hand be subjected to funding cuts, but on the other hand be expected to keep picking up the pieces when DHSC and the NHS launch policies without having the infrastructure in place to effectively implement them.

“We have warned Ministers directly – both by writing to them and in meetings – that rolling out the HRT PPC at this point risks causing confusion for some patients and that it will add to the burden on pharmacies, but to no avail. Government recognises the challenges but is determined to move forwards with the policy.

“DHSC has recognised the impact this will have on pharmacies we are pressing for appropriate financial compensation for pharmacy owners. We have also sought guidance for GPs, and now published our own guidance to try to make the launch go as smoothly as it can for pharmacy teams.”

Key Issues Identified by PSNC

As a consequence of its limited scope, a patient with an HRT PPC will continue to pay the prescription charge for any other (non-HRT) medicines (unless another exemption reason applies). While GPs will be required to write HRT items on separate prescriptions, on occasion both an HRT medicine and another item will be prescribed on the same prescription – a ‘mixed’ prescription. This presents a problem for a patient who has an HRT PPC and the for the pharmacy because a prescription cannot be processed as both ‘exempt’ and ‘paid’ within the NHS prescription processing and pricing systems, explained PSNC.

Regulations have been put in place seeking to avoid such ‘mixed’ prescriptions and to give options to contractors/pharmacist facing ‘mixed’ prescriptions presented by patients with an HRT PPC. DHSC is advising pharmacies to refuse to dispense ‘mixed’ prescriptions to patients with an HRT PPC, unless the patient needs one or more of the prescription items urgently.

“This may be appropriate due to the problems and potential financial risks with processing of ‘mixed’ prescriptions for patients with an HRT PPC.”

PSNC warned the DHSC at the earliest opportunity that suppliers need advance notice to better fit new IT development plans into their roadmaps. The Government’s digital solution involves prescribing systems automating the issuing of listed HRT medicines as single-item prescriptions, but DHSC has not yet confirmed the associated completion timescales.

PSNC remains concerned that ‘mixed’ prescriptions may continue for some time. DHSC has also recommended development work on PMR systems be completed ahead of HRT PPC implementation date of 1 April 2023 to introduce HRT PPC categories within PMR systems.

“As guidanace passage 6.1 (quoted above) makes clear, the Department recognises that there will be associated costs for pharmacy owners until IT solutions are in place. We are in discussion with them about appropriate financial compensation for this.”

More For You

weight-loss websites - your local pharmacist

Many Independents offers a weight loss management programme that doesn’t have a faceless dealer

Pic credit: iStock

Avoid rogue weight-loss websites - your local pharmacist is the safest way to lose those pounds

By Jeremy Meader

More than a quarter of adults in England are considered clinically obese, which puts tremendous strain on healthcare services.

Keep ReadingShow less
Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
Pharmacies warn against buying unlicensed hay fever treatment Kenalog® online

Kenalog® can cause serious mental health problems.

gettyimages

Don’t buy unlicensed hay fever drug Kenalog® online, pharmacies warn

Patients are being urged to avoid buying unlicensed medications such as Kenalog® online to treat hay fever symptoms this spring, as pharmacists report a sharp rise in public interest in the drug.

The National Pharmacy Association (NPA), which represents over 6000 independent community pharmacies, has warned patients that buying medication from unregulated sellers, such as beauty salons and from social media sites, could serious health risks.

Keep ReadingShow less
New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less